Search results for "acids"

showing 10 items of 3520 documents

Effect of Dietaryn-3Polyunsaturated Fatty Acids on Oxidant/Antioxidant Status in Macrosomic Offspring of Diabetic Rats

2014

The aim of this work was to determine the effect of dietaryn-3PUFA on oxidant/antioxidant status,in vitrovery low and low density lipoprotein (VLDL-LDL), and VLDL-LDL-fatty acid composition in macrosomic pups of diabetic mothers. We hypothesized thatn-3PUFA would improve oxidative stress in macrosomia. Diabetes was induced in female Wistar rats fed with the ISIO diet (control) or with the EPAX diet (enriched inn-3PUFAs), by streptozotocin. The macrosomic pups were killed at birth (day 0) and at adulthood (day 90). Lipid parameters and VLDL-LDL-fatty acid composition were investigated. The oxidant/antioxidant status was determined by measuring plasma oxygen radical absorbance capacity (ORAC)…

Malemedicine.medical_specialtyAntioxidantArticle SubjectOxygen radical absorbance capacitymedicine.medical_treatmentlcsh:Medicinemedicine.disease_causedigestive systemAntioxidantsGeneral Biochemistry Genetics and Molecular BiologyDiabetes Mellitus ExperimentalFetal Macrosomiachemistry.chemical_compoundInternal medicineDiabetes mellitusFatty Acids Omega-3medicineAnimalsRats Wistarchemistry.chemical_classificationGeneral Immunology and Microbiologylcsh:Rnutritional and metabolic diseasesLipid metabolismGeneral MedicineOxidantsStreptozotocinmedicine.diseaseDietary FatsRatsOxidative StressEndocrinologychemistryLow-density lipoproteinFemalelipids (amino acids peptides and proteins)Oxidation-ReductionOxidative stressResearch Articlemedicine.drugPolyunsaturated fatty acidBioMed Research International
researchProduct

Early lipoic acid intake protects retina of diabetic mice

2008

The aim of this study was to test the effect of lipoic acid treatment on the retina after a short diabetic insult. Diabetes was induced by alloxan and mice were divided into sub-groups; control, diabetic, diabetic+insulin and all groups received+/-lipoic acid (100 mg/kg body weight) for 3 weeks. GSH content, MDA concentration, GPx activity were measured and electroretinograms (ERG) were recorded. Early administration of lipoic acid to diabetic mice prevented the statistically significant decreases of GSH content and GPx activity and normalized MDA concentration. Moreover, lipoic acid restored electroretinogram b-wave amplitude of diabetic animals to control values. Lipoic acid has a protect…

Malemedicine.medical_specialtyAntioxidantgenetic structuresmedicine.medical_treatmentmedicine.disease_causeBiochemistryAntioxidantsDrug Administration ScheduleRetinaDiabetes Mellitus ExperimentalMicechemistry.chemical_compoundMalondialdehydeInternal medicineDiabetes mellitusAlloxanElectroretinographymedicineAnimalsHypoglycemic AgentsInsulinGlutathione PeroxidaseDiabetic RetinopathyThioctic Acidbusiness.industryInsulinGeneral MedicineGlutathionemedicine.diseaseGlutathioneeye diseasesOxidative StressLipoic acidEndocrinologychemistrylipids (amino acids peptides and proteins)sense organsbusinessErgOxidative stressFree Radical Research
researchProduct

Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the F…

2005

Peroxisome proliferator-activated receptor alpha (PPARalpha) is a nuclear transcription factor regulating multiple genes involved in lipid metabolism. It was shown that a common leucine to valine (L162V) substitution at the PPARalpha gene (PPARA) is functional and affects transactivation activity of PPARalpha ligands, such as PUFA, on a concentration-dependent basis. The current study examined this gene-nutrient interaction in relation to plasma lipid variables in a population-based study consisting of 1003 men and 1103 women participating in the Framingham cohort and consuming their habitual diets. We found significant gene-nutrient interactions between the L162V polymorphism and total PUF…

Malemedicine.medical_specialtyApolipoprotein BAlcohol DrinkingPopulationMedicine (miscellaneous)Peroxisome proliferator-activated receptorPolymorphism Single Nucleotidechemistry.chemical_compoundFramingham Heart StudyInternal medicinemedicineDiabetes MellitusHumansPPAR alphaeducationApolipoproteins CTriglycerideschemistry.chemical_classificationeducation.field_of_studyApolipoprotein C-IIISex CharacteristicsNutrition and DieteticsbiologyTriglycerideSmokingApolipoprotein C-IIILipid metabolismMiddle AgedDietary FatsEndocrinologychemistryAmino Acid SubstitutionCase-Control Studiesbiology.proteinFatty Acids Unsaturatedlipids (amino acids peptides and proteins)FemaleEnergy IntakePolyunsaturated fatty acidThe Journal of nutrition
researchProduct

Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.

1990

Diabetes mellitus is frequently associated with lipid metabolism abnormalities. In the present study the lipid and apolipoprotein profiles have been compared in type II diabetic subjects with (n = 30) and without (n = 30) coronary heart disease (CHD). All subjects were studied after good metabolic control had been achieved. Significant differences in plasma lipids and apolipoproteins were seen in diabetic patients with CHD in comparison with diabetics without CHD. Patients with CHD presented higher total cholesterol, triglyceride, LDL-cholesterol, apo B, apo CII and apo CIII levels and total cholesterol/HDL-cholesterol and LDL-cholesterol HDL-cholesterol ratios and lower HDL-cholesterol val…

Malemedicine.medical_specialtyApolipoprotein BEndocrinology Diabetes and MetabolismLipoproteinsStatistics as TopicCoronary Diseasechemistry.chemical_compoundEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicineHumansRisk factorAgedbiologyTriglyceridebusiness.industryLipid metabolismGeneral MedicineMiddle Agedmedicine.diseaseLipidsEndocrinologyFructosamineApolipoproteinschemistryDiabetes Mellitus Type 2Metabolic control analysisbiology.proteinlipids (amino acids peptides and proteins)FemalebusinessComplicationActa diabetologica latina
researchProduct

Effects of high-intensity circuit training, low-intensity circuit training and endurance training on blood pressure and lipoproteins in middle-aged o…

2013

Background The aim of this study was to determine the physiological effects of an high-intensity circuit training (HICT) on several cardiovascular disease risk factors in healthy, overweight middle-aged subjects, and to compare the effects of HICT to traditional endurance training (ET) and low-intensity circuit training (LICT). Methods Fifty-eight participants (ages 61±3.3 yrs, BMI 29.8±0.9) were randomly assigned to one of the three exercise treatment groups: HICT, LICT and ET. The three groups exercised three times per week, 50 min per session for 12 weeks. Baseline and after intervention anthropometric characteristics: body weight (BW), fat mass (FM); blood pressure: diastolic (DBP) and …

Malemedicine.medical_specialtyApolipoprotein BHdlEndocrinology Diabetes and MetabolismsportsLipoproteinsClinical BiochemistryPhysical ExertionBlood PressureClinical nutritionOverweightCardiovascular disease risk factorsCircuit trainingLdlEndocrinologyEndurance trainingInternal medicinemedicineHumansExercise physiologyExerciseApolipoproteins ATriglyceridesAgedApolipoproteins BBiochemistry medicalCircuit trainingbiologybusiness.industryResistance training strength and conditioningResearchBiochemistry (medical)Cholesterol HDLCholesterol LDLAnthropometryMiddle AgedOverweightExercise TherapyBlood pressureEndocrinologyAdipose Tissuebiology.proteinsports.sportlipids (amino acids peptides and proteins)medicine.symptombusinessLipids in health and disease
researchProduct

Cholesterol and saturated fat intake determine the effect of polymorphisms at ABCG5/ABCG8 genes on lipid levels in children.

2006

Purpose: Analysis of mutations in genes of the cholesterol metabolic pathway has not completely explained the interindividual variability of blood cholesterol concentrations attributed to gene–nutrient interactions. Thus, we analyzed polymorphisms in the ABCG5 and ABCG8 genes, involved in the regulation of intestinal cholesterol absorption, with special interest in a potential interaction with diet to determine lipid levels. Methods: The polymorphisms ABCG5 C1950G (Gln604Glu) and ABCG8 C1895T (Ala640Val) were determined by polymerase chain reaction and restriction analysis in 1227 healthy school children, aged 6 to 8 years. Results: No significant differences were found in blood lipid level…

Malemedicine.medical_specialtyApolipoprotein BLipoproteinsBlood lipidsABCG8Cholesterol Dietarychemistry.chemical_compoundGene FrequencyPolymorphism (computer science)Internal medicineSurveys and QuestionnairesGenotypemedicineHumansATP Binding Cassette Transporter Subfamily G Member 5ChildGenetics (clinical)GeneticsPolymorphism GeneticbiologyBase SequenceCholesterolATP Binding Cassette Transporter Subfamily G Member 8DNADietary FatsLipidsEndocrinologychemistryABCG5biology.proteinIntestinal cholesterol absorptionlipids (amino acids peptides and proteins)ATP-Binding Cassette TransportersFemaleGenetics in medicine : official journal of the American College of Medical Genetics
researchProduct

Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease

2005

Abstract Background Lipoproteins and their subfractions are associated with the incidence of atherosclerotic diseases. In patients with coronary artery disease (CAD), low serum concentrations of high density lipoprotein (HDL) and high low-density lipoproteins (LDL) are correlated to myocardial infarction and cardiovascular death. There is growing evidence indicating that those lipoprotein factors are related to the inflammatory process in atherogenesis. Methods We investigated in a median follow up of 3.9 years the association of HDL, apolipoprotein A-I (apoA-I), LDL, apolipoprotein B (apoB), and triglycerides with the incidence of a combined endpoint (myocardial infarction and cardiovascul…

Malemedicine.medical_specialtyApolipoprotein BLipoproteinsInflammationCoronary Artery DiseaseRisk AssessmentCoronary artery diseasechemistry.chemical_compoundHigh-density lipoproteinRisk FactorsInternal medicinemedicineHumansProspective StudiesMyocardial infarctionProspective cohort studyAgedInflammationUnivariate analysisApolipoprotein A-Ibiologybusiness.industrynutritional and metabolic diseasesMiddle AgedPrognosismedicine.diseasechemistrybiology.proteinCardiologyFemalelipids (amino acids peptides and proteins)medicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersLipoproteinInternational Journal of Cardiology
researchProduct

Ajuga ivaaqueous extract improves reverse cholesterol transport in streptozotocin-induced diabetic rat

2012

AbstractObjectivesThe aim of this study was to determine the effects of Ajuga iva aqueous extract on lecithin : cholesterol acyltransferase (LCAT) activity and amount and composition of high-density lipoprotein (HDL)2 and (HDL)3, in streptozotocin (STZ)-induced diabetic rats.MethodsDiabetes was induced in male Wistar rats by intraperitoneal injection of STZ (60 mg/kg body weight). Diabetic rats (n = 12) were divided into two groups. The diabetic control group (D) received a 20% casein diet and the diabetic treated group received the same diet supplemented with A. iva aqueous extract (0.5 g/100 g diet) (DAi), for 4 weeks.Key findingsTotal cholesterol and HDL3-C were respectively decreased by…

Malemedicine.medical_specialtyApolipoprotein Bmedicine.medical_treatmentIntraperitoneal injectionPharmaceutical ScienceAjugaAjugaDiabetes Mellitus ExperimentalPhosphatidylcholine-Sterol O-AcyltransferaseInternal medicineDiabetes mellitusLecithinsmedicineAnimalsRats WistarPhospholipidsTriglyceridesPharmacologyApolipoprotein A-IbiologyPlant ExtractsChemistryCholesterol HDLReverse cholesterol transportBiological TransportStreptozotocinbiology.organism_classificationmedicine.diseaseRatsCholesterolEndocrinologyAcyltransferaseDietary Supplementsbiology.proteinlipids (amino acids peptides and proteins)Cholesterol EstersPhytotherapymedicine.drugLipoproteinJournal of Pharmacy and Pharmacology
researchProduct

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease

2006

The type of dyslipidemia in patients with peripheral arterial disease (PAD) is still ill defined. PAD patients often show elevated triglycerides and reduced HDL-cholesterol, two lipid abnormalities usually accompanied by decreased LDL size in the "atherogenic lipoprotein phenotype" (ALP). We investigated (1) whether PAD patients have lower LDL size, (2) altered LDL subclass distribution and (3) the prevalence of ALP. We measured plasma lipids and LDL size and subclasses by gradient gel electrophoresis in 31 adults with intermittent claudication and 31 age-BMI-matched controls. Patients had higher prevalence of hypertension (p = .0132), smoking (p < .0020) and diabetes (p = .0024), with lowe…

Malemedicine.medical_specialtyAtherogenic lipoprotein phenotypeLDL sizeTriglyceridechemistry.chemical_compoundRisk FactorsInternal medicineDiabetes mellitusPeripheral arterial diseaseMedicineHumansRisk factorParticle SizeTriglyceridesAgedDyslipidemiasPeripheral Vascular DiseasesTriglyceridebusiness.industryVascular diseaseCholesterolCholesterol HDLCholesterol LDLMiddle Agedmedicine.diseaseAtherosclerosisIntermittent claudicationHDL-cholesterolEndocrinologyPhenotypechemistrylipids (amino acids peptides and proteins)medicine.symptomCardiology and Cardiovascular MedicinebusinessDyslipidemiaLipoprotein
researchProduct

Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial

2020

Treating sarcopenia in older individuals remains a challenge, and nutritional interventions present promising approaches in individuals that perform limited physical exercise. We assessed the efficacy of leucine administration to evaluate whether the regular intake of this essential amino acid can improve muscle mass, muscle strength and functional performance and respiratory muscle function in institutionalized older individuals. The study was a placebo-controlled, randomized, double-blind design in fifty participants aged 65 and over (ClinicalTrials.gov identifier NCT03831399). The participants were randomized to a parallel group intervention of 13 weeks&rsquo

Malemedicine.medical_specialtyBODY-COMPOSITIONrespiratory muscles030209 endocrinology & metabolismPhysical exerciselcsh:TX341-641MASSPlaceboOBSTRUCTIVE PULMONARY-DISEASEelderlyArticlesarcopenia03 medical and health sciencesDOUBLE-BLIND0302 clinical medicineDouble-Blind MethodLeucineInternal medicineSTRENGTHRespiratory musclemedicineMUSCLE PROTEIN-SYNTHESISHumansAMINO-ACIDS030212 general & internal medicineVITAMIN-D SUPPLEMENTATIONEssential amino acidAgedchemistry.chemical_classificationAged 80 and overNutrition and Dieteticsbusiness.industryWHEY-PROTEINmedicine.diseaseClinical trialnutritionchemistrymuscle massSarcopeniaLean body massmuscle strengthFemaleLeucinePHYSICAL PERFORMANCEbusinesslcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct